Company intelligence / Profile preview
Jichuan Pharmaceutical
Taizhou, Jiangsu, Chinajcpharm.com.cn ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Jichuan Pharmaceutical has a broad portfolio of over one hundred products, including both Western medicines and traditional Chinese medicines. Its flagship product Jianwei Xiaoshi oral liquid has demonstrated efficacy in pediatric dyspepsia through modulation of gut microbiota and pancreatic secretion pathways. The company’s revenues have grown steadily, with strong profitability reported for recent years. Many of its products are included in China’s National Medical Insurance Catalog.
- Therapeutic areas
- GastroenterologyPulmonologyCardiovascularOther
- Modalities
- Small moleculeHerbal medicine (Traditional Chinese Medicine)Biologic
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Beyond the preview
Go deeper on Jichuan Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jichuan Pharmaceutical.